| Literature DB >> 32469701 |
Hossein Akbarialiabad1, Mohammad Dahri Dahroud2, Mohammad M Khazaei2, Saeed Razmeh3, Mohammad M Zarshenas1.
Abstract
Neurological disorders and their sequelae, as of the widespread and critical humans' complications, affect the body's nervous systems, organ functions, and behaviors. According to WHO, neurological disorders are currently predicted to affect more than one billion people globally. It is well-established that complementary medicine is one of the high accepted interventions that could have been considered for the management of neurological ailments. The current review aimed to compile all the crucial data reporting the investigation on the conspicuous intervention of green tea (made of Camellia sinensis) and related lead compounds (especially l-theanine, epigallocatechin- 3-gallate, epicatechin-3-gallate, epicatechin, and epigallocatechin) for their neurological activities, mechanisms of action, and clinical properties. According to the documents, green tea exhibits antidepressant, anti-neurodegenerative (e.g., anti-Parkinson and anti-Alzheimer), as well as neuroprotective effects.Chief among them, for offering novel work, it is worth focusing on several related assessments with great attention to more extensive standardized clinical trials, and subsequently more in-depth pharmacokinetic studies to safely introduce this beneficial medicinal food as a neuro-effective agent. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Camellia sinensis; complementary medicine; green tea; neurological disorders; polyphenol; review
Year: 2021 PMID: 32469701 PMCID: PMC8033961 DOI: 10.2174/1570159X18666200529152625
Source DB: PubMed Journal: Curr Neuropharmacol ISSN: 1570-159X Impact factor: 7.363
Neuropharmacological and clinical activities of Green tea.
|
|
|
|
|
|---|---|---|---|
| Electrophysiology, histology, transmission electron microscopy | - Improvement of sciatic nerve deficiencies in GTPs | ||
| - | - | Superoxide dismutase activity/gene expressing | Spinal cord neurons protection from oxidative stress conditions (by GTPs) [ |
| - | - | Use of l-theanine / Reserpine induced orofacial dyskinesia ( | - Neuroprotective effects (Anti-oxidation Neurotransmitter deficiency prevention, anti-neuro-inflammation, Anti-apoptosis) [ |
| - | - | Hydrocephalus oxidative damage/EGCG (50 mg/kg) | - ↓ MDA levels in periventricular white matter [ |
| - | - | Fluoro-Jade-B (FJB) staining/PCA (30 mg/kg) IP injected | - ↓ Neuronal death and oxidative stress in the hippocampus |
| - | - | Cd-induced brain injury/treated with l-theanine (200 mg/kg/day) | - ↓ Brain cadmium level, oxidative damage, MDA, and neuronal cell death Increase in Glutathione level, Inhibition of GSK-3β activation [ |
| - | - | Diminution of MnO2 nanoparticles neurotoxicity | - Prevention of arsenic neurotoxicity effects (↓ Oxidative stress and lipid peroxidation induced by arsenic [ |
| - | - | Rats exposed to trivalent inorganic arsenic/ Green tea (GT) gavage | - ↓ DNA fragmentation, TP53, and COX-II genes expression to attenuate deltamethrin-induced neurotoxicity [ |
| - | - | Administration of 3-nitropropionic acid (21 days, rats)/ GT aqueous extract | - ↓ Harmful NO production, Prevention of striatal neurotransmitters levels alteration, Anti-inflammatory activity (l-theanine treatment) [ |
| - | - | Male Wistar rats/Induction of crush injury/intraperitoneal administration of EGCG | - Upregulation of glutathione reductase (EGCG may indirectly act |
| - | - | Animal study | - ↓ Transient putrescine levels increment ischemic- induced due to EGCG delayed administration [ |
| - | - | Electrophysiological and morphological studies | - Cortical neurons protection from UV light irradiation-related injury by GTPs through inhibition of active BAX expression [ |
| - | - | ||
| Clinical trial & | - Synergistic inhibitory effect of EGCG and fish oil on cerebral β-amyloid deposits and noticeable therapeutic efficacy for AD treatment [ | ||
| - | - | A clinical trial, Four Green tea pills daily for two months | - Prophylaxis effects of a regime containing GT and EGCG modulate against Alzheimer's disease [ |
| - | - | - Facilitates hippocampal synaptic transmission through the dopamine D1/5 receptor-PKA pathway | |
| - | - | Orally administered with l-theanine f 0.1 mg/mL (low dose) and 0.4 mg/mL (high dose) | - Reversion of phosphatidylcholine deregulated metabolism induced by β-amyloid peptide [ |
| Fluoro-Jade B staining/ EGCG ( | - ROS-NO pathway was inhibited by GTPs which resulted in a protective effect against Parkinson's disease [ | ||
| Morris water maze | - Hippocampus proteins upregulation involved in synaptic plasticity, ↓Aβ142 oligomers (long-term administration of GTC: prevention of spatial learning and memory impairment [ | ||
| - | - | Open field test, Step through the test | - GTPs improved stress-related cognitive impairments [ |
| - | - | EEG measurements/ EEG brain mapping instrument | - ↑ The activity of brain waves (putative role of GT in cognitive function) [ |
| - | - | IV infusion of EGCG in acutely injured rats' spinal cord/ LSS, pain behavior test | - Anti-neurodegenerative effect (improvement of tactile allodynia, mechanical nociception, and number of neurons, reduction in lesion size area) [ |
| EGCG (50 mg/kg) effect/Cerebral artery occlusion and reperfusion | - ↓ Infarction volume and neurological deficit total score, ↓MDA level, and oxidized/total glutathione ratio levels (neuroprotective effects) [ | ||
| - | - | Mice middle cerebral artery occlusion and reperfusion/ EGCG | - Proliferation and differentiation improvement of NPCs of Subventricular zone by EGCG (stroke recovery), functional recovery |
| - | - | Animal and experimental design, Surgery, Control behavioral tests, Memory assessments, Biochemical testing, Brain histology | - Prevents deficits in object and social recognition memories, spatial memories and hippocampal oxidative status, intense necrosis in ischemic necrosis cases [ |
| - | - | Western-blot/ RT-PCR/ Tube Formation/ Transwell Migration/ Detection of Apoptosis by Flow Cytometry/ Electron Microscopy/ OGD/R model ( | - Neuroprotective |
| - | - | Excitotoxicity in primary cultured cortical neurons/ MTT and TUNEL assays | - Modulation of inflammatory cytokines, ↓ Oxidative stress in the ischemic brain [ |
| - | - | Experimental ischemia-reperfusion brain injury/ MTT and LDH release/ Cell culture and Trypan blue exclusion/ Immuno-precipitation, Western blot ( | - ↓ Apoptotic cells and ischemia/reperfusion-related increase of eicosanoid concentration and oxidative damage, recovery improvement from active avoidance inhibition caused by ischemia/reperfusion due to GT extract pretreatment [ |
| - | --------------- | ||
| - | Functional neurotoxicity/ Orally applied green tea | - ↓ Changes in the action potential of peripheral nerve and spontaneous cortical activity alteration (Diminution of nervous system effects) [ | |
| - | Synaptic transmission between regions of the hippocampus/ Schaffer collateral ( | - Enhancement of long-term potentiation by EGCG, Alleviation of hippocampal LTP deficiency in a similar fashion as γ-Aminobutyric acid antagonists [ | |
| - | - | - Positive effect of GT and γ-Aminobutyric acid GT against post-stroke depression through decreasing oxidative stress, (restoring normal behavior) behavioral recovery, ↑ endogenous antioxidant defenses and depressive symptoms modulation [ | |
| - | - | Case-control, Antioxidant assay of glutathione, catalase and superoxide dismutase | - Antioxidant activity of |
Abbreviations: *AD: Alzheimer’s disease; DMEM: Dulbecco's Modified Eagle Medium; ECG: Epigallocatechin-3-gallate; EGCG: epigallocatechin-3-gallate; GT: Green Tea; GTC: Green Tea Catechin; GTPs: Green Tea Polyphenols; GSK-3β: Glycogen synthase kinase 3 beta a; HBMVEC: Human Brain Microvascular Endothelial Cell; LDH: Lactate dehydrogenase; LSS: Lumbar spinal stenosis;; LTP: Long-term Potentiation; MDA: Malondialdehyde; MMSE: Mini-Mental State Examination; mTOR: Mammalian Target of Rapamycin; MTT: 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide; NA: Hypernatremia; NO: Nitric Oxide; NPC: Neural Progenitor Cell; 8-OGdG: 8-hydroxy-2-deoxyguanosine; OGD/R: Oxygen-Glucose Deprivation/Reoxygenation; PCA: Principal component analysis; ROS: Reactive Oxygen Species; RT-PCR: Real-time polymerase chain reaction; SOD: Superoxide Dismutase; TP53: Tumor protein P53; TUNEL: Terminal deoxynucleotidyl transferase dUTP nick end labeling.